Rezafunginand caspofungin effective treatment option for invasive candidiasis
Rezafungin and caspofungin effective treatment options for invasive candidiasis suggest a new study published in the Lancet Infectious Diseases. Rezafungin, a new US Food and Drug Administration-approved, long-acting echinocandin to treat candidaemia and invasive candidiasis, was efficacious with a similar safety profile to caspofungin in clinical trials. We conducted pooled analyses of the phase 2 […]